Contract Research Solutions for Respiratory Diseases

Online Inquiry

First Name *

Last Name *

Business Email *

Phone

Company/Institution

Job Title

Services of Interest *

When do you expect your project to start?

Project Description

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Expert Biomarker Analysis for Respiratory Disease Models

Inquiry

Inhalation toxicology, drug efficacy studies, and mechanism of action research for respiratory conditions require precise, reliable data. At Ace Therapeutics, we specialize in providing comprehensive biomarker analysis services tailored specifically for respiratory disease research. Our platforms are designed to support preclinical investigators in quantifying disease progression and therapeutic intervention with high specificity and reproducibility.

Why Biomarker Analysis is Critical in Respiratory Research

Biomarkers serve as the cornerstone of translational research, offering objective indicators of normal biological processes, pathogenic processes, or pharmacological responses. In respiratory diseases—ranging from asthma and COPD to pulmonary fibrosis and acute lung injury—accurate biomarker quantification helps validate animal models and assess drug target engagement.

Our services bridge the gap between complex disease pathology and actionable data, ensuring your preclinical pipeline is supported by robust quantitative evidence.

Our Biomarker Analysis Services

We offer a broad spectrum of analytical techniques to quantify a wide array of respiratory biomarkers from various biological matrices (BALF, serum, plasma, lung tissue homogenates).

Category	Specific Analytes	Typical Matrices
Inflammatory Cytokines	IL-1β, IL-6, TNF-α, IL-10, IL-13, IL-17, IFN-γ	BALF, Serum, Lung Homogenate
Oxidative Stress Markers	MDA, 8-OHdG, SOD, GSH, Catalase, ROS	Lung Tissue, Plasma, BALF
Proteases & Anti-proteases	Neutrophil Elastase, MMP-2, MMP-9, TIMP-1	BALF, Lung Tissue
Growth Factors & Fibrosis	TGF-β1, PDGF, VEGF, Hydroxyproline	Lung Tissue, Serum
Cell Damage Markers	LDH, Albumin (vascular leakage), Total Protein	BALF, Serum

Key Advantages of Our Approach

Multiplex Capabilities: We utilize advanced technologies to quantify multiple cytokines simultaneously from a single, small-volume sample.
Custom Assay Development: If your target biomarker is not listed, our team can work with you to develop and validate a specific assay for your needs.
Quantitative Readouts: We emphasize absolute quantification (e.g., pg/mL, μmol/L) where possible to provide data that is comparable across studies.
Histological Integration: For a complete picture, biomarker data can be correlated with histopathological findings (e.g., immunohistochemistry for specific markers).

Biomarkers Across Key Indications

We understand that different respiratory conditions have distinct molecular signatures. Our analytical protocols are optimized to capture the most relevant biomarkers for your specific model.

Asthma Models

Key Markers: Th2 cytokines (IL-4, IL-5, IL-13), Eotaxin, IgE.
Objective: Quantify airway inflammation and Th2-driven immune responses.

Pulmonary Fibrosis Models

Key Markers: Hydroxyproline (collagen content), TGF-β1, Fibronectin, MMPs/TIMPs.
Objective: Assess extracellular matrix remodeling and fibrotic burden.

COPD & Emphysema Models

Key Markers: Neutrophil elastase, MMP-9, TNF-α, IL-8/KC (rodent), Oxidative stress markers.
Objective: Evaluate chronic inflammation, proteases/anti-proteases imbalance, and oxidative damage.

Acute Lung Injury (ALI) / ARDS Models

Key Markers: Protein leakage (BALF), LDH, Inflammatory cascade (IL-1β, IL-6), Myeloperoxidase (MPO) activity.
Objective: Assess alveolar-capillary barrier integrity and neutrophilic inflammation.

Technology Platforms

To ensure accuracy and speed, we employ a range of validated platforms. The choice of platform depends on the sensitivity required and the nature of the biomarker.

Enzyme-Linked Immunosorbent Assay (ELISA): For single-plex, high-sensitivity quantification of specific proteins.
Multiplex Immunoassays: For high-throughput profiling of cytokine/chemokine panels.
Colorimetric & Fluorescent Assays: For oxidative stress markers (MDA, GSH) and enzyme activities (MPO, elastase).
qRT-PCR: For gene expression analysis of inflammatory or fibrotic markers in lung tissue.
Histology & IHC: Spatial localization of biomarkers within the lung architecture (e.g., collagen deposition visualized by Masson's Trichrome).

Advance Your Preclinical Respiratory Research

Incorporating detailed biomarker analysis into your study design provides the mechanistic insights needed to advance drug development. Whether you are screening new chemical entities or validating a target in a complex disease model, Ace Therapeutics offers the analytical rigor and respiratory expertise you need.

Frequently Asked Questions (FAQs)

What types of samples can I submit for biomarker analysis?

We routinely process mouse and rat samples, including Bronchoalveolar Lavage Fluid (BALF), plasma, serum, and whole lung tissue (homogenates or fixed sections for IHC). Please contact us to discuss requirements for other sample types or species.

How do you ensure the accuracy of the biomarker measurements?

We follow strict Standard Operating Procedures (SOPs). Each assay run includes standard curves, quality control samples, and blanks to ensure validity. Our protocols are designed to minimize variability and provide reproducible quantitative data essential for preclinical decision-making.

Can you help me choose the right biomarkers for my study?

Absolutely. Our scientific team has extensive experience in respiratory pharmacology. We can provide guidance on selecting a biomarker panel that aligns with your specific disease model and drug mechanism of action, helping you capture the most relevant data.

Do you offer multiplex analysis for small sample volumes?

Yes. One of the main advantages of our multiplex platforms is the ability to quantify up to 10-30 different analytes from a single 50µL sample of BALF or serum, which is particularly beneficial for murine studies where sample volume is limited.

How is the data delivered after analysis?

You will receive a comprehensive report containing raw data, calculated concentrations, statistical summaries, and a detailed methodology section, ensuring full transparency and easy integration into your study reports or publications.